Cardiac hypertrophy and fibrosis

July 9, 2018

Insulate your heart against cardiac dysfunction with flu vaccine: Influenza A (H1N1) vaccine-based adjunct therapy for cardiac hypertrophy and fibrosis: Influenza A (H1N1)/Flu vaccine decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 9/July/2018, 11.41 am

Insulate your heart against cardiac dysfunction with flu vaccine: Influenza A (H1N1) vaccine-based adjunct therapy for cardiac hypertrophy and fibrosis: Influenza A (H1N1)/Flu vaccine decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 9/July/2018, 11.41 am https://genomediscovery.org/wp-content/uploads/2018/07/H1N1-attenuates-pathogenesis-associated-with-cardiac-hypertrophy-and-fibrosis.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/07/H1N1-attenuates-pathogenesis-associated-with-cardiac-hypertrophy-and-fibrosis.jpg July 9, 2018 July 9, 2018

Introduction: What they say: A recent study from the Institute of Pharmacology and Toxicology, Technical University Munich (TUM), 80802, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich…

July 5, 2018

Protect your heart from Myocardial dysfunction and cardiac ageing with Influenza vaccine : Influenza A (H1N1) vaccine induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 5/July/2018, 7.08 am

Protect your heart from Myocardial dysfunction and cardiac ageing with Influenza vaccine : Influenza A (H1N1) vaccine induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 5/July/2018, 7.08 am https://genomediscovery.org/wp-content/uploads/2018/07/Influenza-A-H1N1-vaccine-attenuates-myocardial-cell-death-and-fibrosis.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/07/Influenza-A-H1N1-vaccine-attenuates-myocardial-cell-death-and-fibrosis.jpg2_.jpg July 5, 2018 July 5, 2018

What they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March 2013 issue of of the journal Nature, by Prof Dimmler,…

July 2, 2018

Protect your heart from Myocardial dysfunction and cardiac ageing with Tuberculosis BCG vaccine: BCG vaccine induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 2/July/2018, 11.55 am

Protect your heart from Myocardial dysfunction and cardiac ageing with Tuberculosis BCG vaccine: BCG vaccine induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 2/July/2018, 11.55 am https://genomediscovery.org/wp-content/uploads/2018/07/BCG-vaccine-attenuates-myocardial-cell-death-and-fibrosis-following-acute-myocardial-infarction.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/07/BCG-vaccine-attenuates-myocardial-cell-death-and-fibrosis-following-acute-myocardial-infarction.jpg July 2, 2018 July 2, 2018

July 2, 2018

Bacillus Calmette Guerin (BCG) vaccine-based adjunct therapy for cardiac hypertrophy and fibrosis: BCG vaccine decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function, via up regulation of its target gene, 2/July/2018, 11.13 am

Bacillus Calmette Guerin (BCG) vaccine-based adjunct therapy for cardiac hypertrophy and fibrosis: BCG vaccine decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function, via up regulation of its target gene, 2/July/2018, 11.13 am https://genomediscovery.org/wp-content/uploads/2018/07/BCG-vaccine-attenuates-cardiac-hypertrophy-and-fibrosis-through-down-regulation-of-MiR291.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/07/BCG-vaccine-attenuates-cardiac-hypertrophy-and-fibrosis-through-down-regulation-of-MiR291.jpg2_.jpg July 2, 2018 July 2, 2018

June 26, 2018

Hypertonic saline-based adjunct therapy for cardiac hypertrophy and fibrosis: Hypertonic saline decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 26/June/2017, 10.27 pm

Hypertonic saline-based adjunct therapy for cardiac hypertrophy and fibrosis: Hypertonic saline decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 26/June/2017, 10.27 pm https://genomediscovery.org/wp-content/uploads/2018/06/Hypertonic-saline-attenuates-cardiac-hypertrophy-and-fibrosis-through-down-regulation-of-miR-29.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/06/Hypertonic-saline-attenuates-cardiac-hypertrophy-and-fibrosis-through-down-regulation-of-miR-29.jpg June 26, 2018 November 27, 2018

June 19, 2018

Natural product-derived therapy for cardiac hypertrophy and fibrosis: A pharmaceutical mixture encompassing Sulforaphane, Myricitrin and Aspalathin (SMA) decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 19/June/2017, 10.36 pm

Natural product-derived therapy for cardiac hypertrophy and fibrosis: A pharmaceutical mixture encompassing Sulforaphane, Myricitrin and Aspalathin (SMA) decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 19/June/2017, 10.36 pm https://genomediscovery.org/wp-content/uploads/2018/06/SMA-attenuate-pathogenesis-associated-with-cardiac-hypertrophy-through-down-regulation-of-MiR-29.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/06/SMA-attenuate-pathogenesis-associated-with-cardiac-hypertrophy-through-down-regulation-of-MiR-29.jpg June 19, 2018 June 19, 2018

Protect your heart from Myocardial dysfunction and cardiac ageing with Influenza vaccine : Influenza A (H1N1) vaccine induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 5/July/2018, 7.08 am

Protect your heart from Myocardial dysfunction and cardiac ageing with Tuberculosis BCG vaccine: BCG vaccine induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 2/July/2018, 11.55 am

Popular Post